OPA1 and telomere syndrome: We therefore probed the involvement of the OMA1/OPA1 pathway in a mouse sarcoma model and tested whether the level of OMA1 and OPA1 expressions was associated with clinical outcome and immune variables in human soft tissue sarcomas (STS).